Abstract:Spike protein sequences in SARS-CoV-2 have been employed for vaccine epitopes, but many short constituent sequences (SCSs) in the spike protein are present in the human proteome, suggesting that some anti-spike antibodies induced by infection or vaccination may be autoantibodies against human proteins. To evaluate this possibility of "molecular mimicry" in silico and in vitro, we exhaustively identified common SCSs (cSCSs) found both in spike and human proteins bioinformatically. The commonality of SCSs between the two systems seemed to be coincidental, and only some cSCSs were likely to be relevant to potential self-epitopes based on three-dimensional information. Among three antibodies raised against cSCS-containing spike peptides, only the antibody against EPLDVL showed high affinity for the spike protein and reacted with an EPLDVL-containing peptide from the human unc-80 homolog protein. Western blot analysis revealed that this antibody also reacted with several human proteins expressed mainly in the small intestine, ovary, and stomach. Taken together, these results showed that most cSCSs are likely incapable of inducing autoantibodies but that at least EPLDVL functions as a self-epitope, suggesting a serious possibility of infection-induced or vaccine-induced autoantibodies in humans. High-risk cSCSs, including EPLDVL, should be excluded from vaccine epitopes to prevent potential autoimmune disorders.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the molecular mimicry phenomenon between short constituent sequences (SCSs) in the SARS - CoV - 2 spike protein and the corresponding sequences in the human proteome, in order to determine whether these common short constituent sequences (cSCSs) may lead to the production of autoantibodies. Specifically, through bioinformatics and in - vitro experimental methods, the researchers systematically identified the SCSs shared between the SARS - CoV - 2 spike protein and the human proteome, and further analyzed whether these cSCSs could act as potential autoantigenic epitopes, thereby triggering autoimmune responses after infection or vaccination. The main purpose of the study is to provide a theoretical basis for safer vaccine epitope design, avoid using epitopes that may induce autoantibodies, and reduce the risk of autoimmune diseases caused by vaccines. Through this study, the author hopes to provide guidance for future vaccine development and ensure the safety and effectiveness of vaccines.

In Silico and In Vitro Evaluation of the Molecular Mimicry of the SARS-CoV-2 Spike Protein by Common Short Constituent Sequences (cSCSs) in the Human Proteome: Toward Safer Epitope Design for Vaccine Development